Viewing Study NCT02903160


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-03-04 @ 11:48 AM
Study NCT ID: NCT02903160
Status: COMPLETED
Last Update Posted: 2024-02-07
First Post: 2016-09-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Sponsor: Icahn School of Medicine at Mount Sinai
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-13
Start Date Type: ACTUAL
Primary Completion Date: 2021-11-15
Primary Completion Date Type: ACTUAL
Completion Date: 2021-11-15
Completion Date Type: ACTUAL
First Submit Date: 2016-09-07
First Submit QC Date: None
Study First Post Date: 2016-09-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2023-12-01
Results First Submit QC Date: None
Results First Post Date: 2024-02-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-16
Last Update Post Date: 2024-02-07
Last Update Post Date Type: ACTUAL